The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $53.85

Today's change-0.09 -0.17%
Updated September 2 9:56 AM EDT. Delayed by at least 15 minutes.
 

Align Technology Inc

Nasdaq: ALGN
Last

(U.S.) $53.85

Today's change-0.09 -0.17%
Updated September 2 9:56 AM EDT. Delayed by at least 15 minutes.

Align Technology Inc down (U.S.)$0.09

Align Technology Inc is lower today, dropping (U.S.)$0.09 or 0.17% to (U.S.)$53.85. Over the last five days, shares have lost 3.75% and are down 3.68% for the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $54.49
  • Previous close(U.S.) $53.94
  • High(U.S.) $54.49
  • Low(U.S.) $53.84
  • Bid / Ask(U.S.) $53.80 / (U.S.) $53.94
  • YTD % change-3.68%
  • Volume40,195
  • Average volume (10-day)677,659
  • Average volume (1-month)596,435
  • Average volume (3-month)804,918
  • 52-week range(U.S.) $43.27 to (U.S.) $66.53
  • Beta2.08
  • Trailing P/E30.30×
  • P/E 1 year forward33.67×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $1.78
Updated September 2 9:56 AM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+18.25%

Based on its net profit margin of 18.25%, Align Technology Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.89%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue209198199190
Total other revenue--------
Total revenue209198199190
Gross profit159151151145
Total cost of revenue51474845
Total operating expense167149147138
Selling / general / administrative101888681
Research & development16141313
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)----00
Other operating expenses, total--------
Operating income42495152
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax42475050
Income after tax31364038
Income tax, total11111011
Net income31364038
Total adjustments to net income--------
Net income before extra. items31364038
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items31364038
Inc. avail. to common incl. extra. items31364038
Diluted net income31364038
Dilution adjustment00----
Diluted weighted average shares81828282
Diluted EPS excluding extraordinary itemsvalue per share0.390.440.480.47
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.390.440.480.47